Stay updated on Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Sign up to get notified when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.

Latest updates to the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-status notice and Revision: v3.4.1.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a government funding notice about potential delays and updated the site to version v3.4.1; removed version v3.4.0.SummaryDifference0.2%

- Check28 days agoChange DetectedMinor UI/text updates include showing the glossary toggle, capitalization adjustments for QC criteria text, and a new revision/version notice (v3.4.0 replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedMinor internal labeling update: the page now shows Revision: v3.3.4, replacing v3.3.3, with no changes to study data, eligibility criteria, or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section updated to include the full list of participating sites across multiple states, with revision updated to v3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedThe revision label on the page updated from v3.2.0 to v3.3.2, indicating a metadata update rather than a change to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Enter your email address, and we'll notify you when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.